Providing Access: Differences in Pediatric Portal Activation Begin at Patient Check-in

Ruth A Bush1,2, Vijaya M Vemulakonda3,4, Andrew C Richardson5

  • 1Hahn School of Nursing and Health Science, Beyster Institute for Nursing Research, University of San Diego, San Diego, California, United States.

Applied Clinical Informatics
|September 12, 2019
PubMed

Insights

Patient portal activation in pediatric urology is limited, with less than half of eligible patients offered access. Demographic factors like preferred language and race influence portal uptake, highlighting disparities in digital health tool adoption.

Area of Science:

  • Digital Health
  • Health Informatics
  • Pediatric Healthcare

Background:

  • Patient portals, utilizing electronic health records (EHR), aim to improve participatory medicine.
  • Existing research indicates barriers to patient portal adoption among minority adults and non-English speakers.
  • Limited data exists on patient portal utilization specifically within pediatric populations.

Purpose of the Study:

  • To investigate the patterns of patient portal offers and activation among pediatric urology patients.
  • To compare portal utilization across two geographically distinct tertiary pediatric hospitals.

Main Methods:

  • A retrospective analysis of electronic portal audit records from 2011 to 2016 was performed.
  • The study included pediatric patients (≤18 years) with at least one outpatient urology visit.
  • Multivariate analysis examined utilization differences between parents/caregivers and adolescents.

Main Results:

  • Out of 44,608 eligible individuals, 48.9% were offered a patient portal activation code, and 19.3% activated access.
  • Portal offer and activation were significantly associated with hospital site, being female, Asian or white race/ethnicity, non-Hispanic status, and English as preferred language.
  • Logistic regression confirmed associations between demographic factors and portal offer/activation.

Conclusions:

  • Demographic variations in patient portal access begin with disparities in offer rates.
  • Less than half of patients offered portal access subsequently activated their accounts.
  • Preferred language, race/ethnicity, and clinic location significantly impact portal activation likelihood in pediatric specialty care, indicating many patients are not offered these digital tools.
Abstract

Related Concept Videos

Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

This article provides comprehensive step-by-step instructions for the acquisition of whole-body 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) PET/MRI scans for cancer staging of pediatric patients. The protocol was developed for children above 6 years, or old enough to comply with breath-hold instructions, but can be used for general anesthesia patients as...
15.2K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Transarterial chemoembolization (TACE) is the standard therapy for patients in the intermediate stage of hepatocellular carcinoma and is typically performed through femoral artery access. Compared with transfemoral access, transradial access (TRA) can decrease the rate of bleeding complications and improve patient tolerance. A method is presented here to perform transarterial chemoembolization via radial artery...
6.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

The isolated-check visual evoked potential (icVEP) method is implemented here to assess the magnocellular ON pathway that is initially damaged in glaucoma. The study shows standard operative procedures using icVEP to obtain reliable results. It is proved to serve as a useful objective diagnosing technology for the early detection of...
6.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
258
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
196